$VRTX
VERTEX PHARMACEUTICALS INC / MA

2021 Q4 Form 10-Q Financial Statement

#000087532021000033 Filed on November 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $2.073B $1.984B $1.538B
YoY Change 27.32% 28.99% 61.95%
Cost Of Revenue $247.4M $236.5M $186.2M
YoY Change 21.8% 27.03% 41.14%
Gross Profit $1.825B $1.748B $1.352B
YoY Change 28.11% 29.26% 65.31%
Gross Profit Margin 88.06% 88.08% 87.9%
Selling, General & Admin $255.2M $198.2M $184.6M
YoY Change 20.45% 7.39% 15.58%
% of Gross Profit 13.98% 11.34% 13.65%
Research & Development $694.3M $493.8M $493.5M
YoY Change 48.8% 0.05% -11.23%
% of Gross Profit 38.04% 28.25% 36.5%
Depreciation & Amortization $33.83M $31.70M $26.70M
YoY Change 15.47% 18.71% 3.09%
% of Gross Profit 1.85% 1.81% 1.97%
Operating Expenses $947.5M $691.9M $678.0M
YoY Change 39.65% 2.05% -5.25%
Operating Profit $877.7M $1.055B $672.2M
YoY Change 17.69% 56.87% 576.75%
Interest Expense -$1.796M $32.54M $13.86M
YoY Change -111.03% 134.84% -4.76%
% of Operating Profit -0.2% 3.09% 2.06%
Other Income/Expense, Net -$4.973M $42.37M $84.39M
YoY Change -103.17% -49.79% -365.81%
Pretax Income $871.0M $1.083B $745.9M
YoY Change -1.99% 45.16% 955.49%
Income Tax $100.8M $230.8M $78.44M
% Of Pretax Income 11.58% 21.32% 10.52%
Net Earnings $770.1M $851.9M $667.4M
YoY Change 27.46% 27.64% 1060.39%
Net Earnings / Revenue 37.16% 42.94% 43.39%
Basic Earnings Per Share $3.30 $2.56
Diluted Earnings Per Share $2.997M $3.28 $2.53
COMMON SHARES
Basic Shares Outstanding 254.3M shares 257.9M shares 260.4M shares
Diluted Shares Outstanding 259.7M shares 264.1M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.525B $6.961B $6.151B
YoY Change 13.0% 13.17% 53.93%
Cash & Equivalents $6.795B $6.276B $5.358B
Short-Term Investments $729.9M $685.2M $793.0M
Other Short-Term Assets $187.2M $457.8M $270.0M
YoY Change 134.88% 69.57% 54.29%
Inventory $353.1M $333.5M $245.5M
Prepaid Expenses $83.50M
Receivables $1.137B $1.100B $791.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.561B $8.853B $7.458B
YoY Change 17.55% 18.69% 56.13%
LONG-TERM ASSETS
Property, Plant & Equipment $1.424B $1.355B $920.9M
YoY Change 10.93% 47.1% 25.55%
Goodwill $1.002B $1.002B $1.002B
YoY Change 0.22% 0.0% 123.93%
Intangibles $400.0M $400.0M $400.0M
YoY Change 0.0% 0.0%
Long-Term Investments $85.80M $35.90M $21.00M
YoY Change 308.57% 70.95%
Other Assets $110.8M $75.52M $372.3M
YoY Change 124.75% -79.72% 365.45%
Total Long-Term Assets $3.872B $3.766B $3.843B
YoY Change 7.01% -2.0% 40.39%
TOTAL ASSETS
Total Short-Term Assets $9.561B $8.853B $7.458B
Total Long-Term Assets $3.872B $3.766B $3.843B
Total Assets $13.43B $12.62B $11.30B
YoY Change 14.3% 11.65% 50.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $195.0M $127.9M $107.8M
YoY Change 25.73% 18.63% 16.49%
Accrued Expenses $1.679B $1.585B $1.704B
YoY Change 19.47% -6.97% 45.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.142B $1.914B $2.004B
YoY Change 14.09% -4.48% 44.29%
LONG-TERM LIABILITIES
Long-Term Debt $509.8M $513.3M $547.0M
YoY Change -5.42% -6.17% 0.92%
Other Long-Term Liabilities $116.8M $108.5M $428.5M
YoY Change 7.75% -74.69% 5507.43%
Total Long-Term Liabilities $116.8M $108.5M $428.5M
YoY Change 7.75% -74.69% 5507.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.142B $1.914B $2.004B
Total Long-Term Liabilities $116.8M $108.5M $428.5M
Total Liabilities $3.333B $3.088B $3.168B
YoY Change 8.73% -2.53% 40.11%
SHAREHOLDERS EQUITY
Retained Earnings $3.201B $2.431B $254.5M
YoY Change 272.75% 855.15% -110.45%
Common Stock $6.883B $7.089B $7.920B
YoY Change -12.83% -10.5% 3.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.10B $9.531B $8.133B
YoY Change
Total Liabilities & Shareholders Equity $13.43B $12.62B $11.30B
YoY Change 14.3% 11.65% 50.4%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $770.1M $851.9M $667.4M
YoY Change 27.46% 27.64% 1060.39%
Depreciation, Depletion And Amortization $33.83M $31.70M $26.70M
YoY Change 15.47% 18.71% 3.09%
Cash From Operating Activities $995.0M $927.2M $907.8M
YoY Change 102.44% 2.14% 171.15%
INVESTING ACTIVITIES
Capital Expenditures -$61.72M -$52.52M -$174.8M
YoY Change 29.38% -69.95% 619.34%
Acquisitions
YoY Change
Other Investing Activities -$72.28M -$430.0K -$73.10M
YoY Change -124.81% -99.41% -67.47%
Cash From Investing Activities -$134.0M -$52.95M -$248.0M
YoY Change -154.96% -78.65% -0.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -336.2M -656.7M -140.7M
YoY Change 168.56% 366.71% -789.71%
NET CHANGE
Cash From Operating Activities 995.0M 927.2M 907.8M
Cash From Investing Activities -134.0M -52.95M -248.0M
Cash From Financing Activities -336.2M -656.7M -140.7M
Net Change In Cash 524.8M 217.6M 519.1M
YoY Change -13.99% -58.08% 388.79%
FREE CASH FLOW
Cash From Operating Activities $995.0M $927.2M $907.8M
Capital Expenditures -$61.72M -$52.52M -$174.8M
Free Cash Flow $1.057B $979.7M $1.083B
YoY Change 95.98% -9.5% 201.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
VERTEX PHARMACEUTICALS INC / MA
dei Entity Central Index Key
EntityCentralIndexKey
0000875320
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-19319
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
dei Entity Address Address Line1
EntityAddressAddressLine1
50 Northern Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3039129
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02210
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
341-6100
dei Security12b Title
Security12bTitle
Common Stock, $0.01 Par Value Per Share
dei Trading Symbol
TradingSymbol
VRTX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
254251938 shares
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1984164000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1538271000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5501839000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4577863000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
236512000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
186182000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
656813000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
533199000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
493751000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
672241000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1100000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
493497000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2356814000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1362953000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
198189000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
184551000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
584935000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
558613000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1200000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1800000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12600000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
929652000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
866030000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3597462000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2467365000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1054512000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1904377000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2110498000 USD
CY2021Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1116000 USD
CY2020Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3100000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3714000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
19919000 USD
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-15255000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13856000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-46411000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-41863000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
42368000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
84386000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2234000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
139621000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1082741000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
745871000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1859446000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2228175000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
230813000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78437000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
287456000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
120718000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
851928000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
667434000 USD
us-gaap Net Income Loss
NetIncomeLoss
1571990000 USD
us-gaap Net Income Loss
NetIncomeLoss
2107457000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.30
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.10
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.28
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.98
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
257876000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260392000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
258740000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260313000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259707000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264079000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
260877000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264031000 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
851928000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
667434000 USD
us-gaap Net Income Loss
NetIncomeLoss
1571990000 USD
us-gaap Net Income Loss
NetIncomeLoss
2107457000 USD
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-56000 USD
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1132000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-329000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
818000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-9600000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
7600000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-21200000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
7300000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
34766000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-26313000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
77011000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-27211000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1986000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
584000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3335000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12616000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
36696000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-26861000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
80017000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39009000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
888624000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
640573000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1652007000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2068448000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6275698000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5988187000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
685187000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
670710000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1100372000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
885352000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
333456000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
280777000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
457827000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
308353000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
8852540000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
8133379000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1042347000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
958534000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
1002158000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1002158000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
400000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
400000000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
933839000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
882779000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
312343000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
325564000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
75518000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49394000 USD
CY2021Q3 us-gaap Assets
Assets
12618745000 USD
CY2020Q4 us-gaap Assets
Assets
11751808000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
127863000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
155139000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1584992000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1404971000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
201409000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
317423000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1914264000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1877533000 USD
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
513255000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
539042000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
363545000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350463000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
188500000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
189600000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
108473000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
108355000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
3088037000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
3064993000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2430659000 USD
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
256206000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
256206000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
259890000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
259890000 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2562000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2599000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
7085950000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
7894027000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11537000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-68480000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
858669000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
9530708000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
8686815000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12618745000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11751808000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
7519242000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-26861000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
667434000 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
108007000 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
40528000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
21704000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
100489000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
8133473000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
9196396000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
36696000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
851928000 USD
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
642273000 USD
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
28559000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
12867000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
103653000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
9530708000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
6085244000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39009000 USD
us-gaap Net Income Loss
NetIncomeLoss
2107457000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
408033000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
179775000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
232079000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
335510000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
8133473000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
8686815000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
80017000 USD
us-gaap Net Income Loss
NetIncomeLoss
1571990000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1067225000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
134223000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
66729000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
326605000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
9530708000 USD
us-gaap Net Income Loss
NetIncomeLoss
1571990000 USD
us-gaap Net Income Loss
NetIncomeLoss
2107457000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
322792000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
332434000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
91768000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
80160000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1100000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12600000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-112654000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
65110000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
4993000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
140866000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-20588000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-52371000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
231166000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
151191000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
65827000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
94907000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
107672000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
264909000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-22043000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16153000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
254157000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
451084000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-67333000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
296477000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1648507000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2761973000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
447759000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
246937000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
452133000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
184419000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
173285000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
212109000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
37991000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
19327000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
34592000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
179775000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
0 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
149595000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-206902000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-144359000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
67289000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
234854000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1057225000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
408033000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
134223000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
31378000 USD
vrtx Proceeds From Finance Leases
ProceedsFromFinanceLeases
12647000 USD
vrtx Proceeds From Finance Leases
ProceedsFromFinanceLeases
8642000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
4339000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4399000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1141765000 USD
us-gaap Interest Paid Net
InterestPaidNet
40769000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-380089000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8472000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2779000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
291368000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2240304000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5988845000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3120681000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6280213000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5360985000 USD
us-gaap Interest Paid Net
InterestPaidNet
42698000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
381533000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
81684000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</span></div>
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
104100000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
191500000 USD
CY2021Q3 vrtx Collaborative Arrangement Research And Development Expenses
CollaborativeArrangementResearchAndDevelopmentExpenses
26800000 USD
vrtx Collaborative Arrangement Research And Development Expenses
CollaborativeArrangementResearchAndDevelopmentExpenses
986800000 USD
CY2020Q3 vrtx Collaborative Arrangement Up Front License Fee
CollaborativeArrangementUpFrontLicenseFee
80100000 USD
vrtx Collaborative Arrangement Up Front License Fee
CollaborativeArrangementUpFrontLicenseFee
143300000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
851928000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
667434000 USD
us-gaap Net Income Loss
NetIncomeLoss
1571990000 USD
us-gaap Net Income Loss
NetIncomeLoss
2107457000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
257876000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260392000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
258740000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260313000 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
19000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
12000 shares
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
10000 shares
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
17000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259707000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264079000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
260877000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264031000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.30
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.10
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.28
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.98
CY2020Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
51427000 USD
CY2020 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
144354000 USD
CY2021Q3 us-gaap Cash
Cash
2700000000 USD
CY2020Q4 us-gaap Cash
Cash
2800000000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
189600000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1100000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
188500000 USD
CY2021Q3 us-gaap Cash
Cash
2700000000 USD
CY2020Q4 us-gaap Cash
Cash
2800000000 USD
CY2021Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
69418000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
150263000 USD
us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
917000 USD
CY2021Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
218764000 USD
CY2020 us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
0 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
195781000 USD
CY2021Q3 vrtx Debtand Equity Securities Cost
DebtandEquitySecuritiesCost
535836000 USD
CY2021Q3 vrtx Debtand Equity Securities Unrealized Gain
DebtandEquitySecuritiesUnrealizedGain
150341000 USD
CY2021Q3 vrtx Debtand Equity Securities Unrealized Loss
DebtandEquitySecuritiesUnrealizedLoss
990000 USD
CY2021Q3 vrtx Debtand Equity Securities Fair Value
DebtandEquitySecuritiesFairValue
685187000 USD
CY2020Q4 vrtx Debtand Equity Securities Cost
DebtandEquitySecuritiesCost
526022000 USD
CY2020Q4 vrtx Debtand Equity Securities Unrealized Gain
DebtandEquitySecuritiesUnrealizedGain
144767000 USD
CY2020Q4 vrtx Debtand Equity Securities Unrealized Loss
DebtandEquitySecuritiesUnrealizedLoss
79000 USD
CY2020Q4 vrtx Debtand Equity Securities Fair Value
DebtandEquitySecuritiesFairValue
670710000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4077185000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3615982000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
4014441000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3526185000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
62744000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
89797000 USD
CY2020Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4077185000 USD
CY2021Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3615982000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2021Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
46679000 USD
CY2020Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
69834000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
4993000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
102317000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
51300000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
49181000 USD
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-30836000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
80017000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-32711000 USD
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
102996000 USD
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
6298000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39009000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
42368000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
84386000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2234000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
139621000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
45990000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
46232000 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
192650000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
161324000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
94816000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
73221000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
333456000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
280777000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
658000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3076000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
950000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3814000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
332434000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
21556000 USD
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
99539000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
322792000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
332434000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
102996000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
99539000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
322792000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
35295000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
73663000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
130692000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
81440000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
64244000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
249129000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
201742000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1082741000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
745871000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1859446000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2228175000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
230813000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78437000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
287456000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
120718000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.11
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.15
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.05
vrtx Effective Income Tax Rate Reconciliation Intra Entity Transfer Of Intellectual Property Rights Amount
EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualPropertyRightsAmount
-209000000 USD
CY2021Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
89000000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
75800000 USD
vrtx Number Of Credit Agreements
NumberOfCreditAgreements
2 credit_agreement
CY2021Q3 vrtx Indemnification Claims
IndemnificationClaims
0 USD
CY2020Q4 vrtx Contingent Liabilities
ContingentLiabilities
0 USD
CY2021Q3 vrtx Contingent Liabilities
ContingentLiabilities
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5988187000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6275698000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3109322000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5358087000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5988845000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6280213000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3120681000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5360985000 USD

Files In Submission

Name View Source Status
0000875320-21-000033-index-headers.html Edgar Link pending
0000875320-21-000033-index.html Edgar Link pending
0000875320-21-000033.txt Edgar Link pending
0000875320-21-000033-xbrl.zip Edgar Link pending
a2021q310-qexhibit101.htm Edgar Link pending
a2021q310-qexhibit102.htm Edgar Link pending
a2021q310-qexhibit103.htm Edgar Link pending
a2021q310-qexhibit104.htm Edgar Link pending
a2021q310-qexhibit311.htm Edgar Link pending
a2021q310-qexhibit312.htm Edgar Link pending
a2021q310-qexhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0a.jpg Edgar Link pending
image_1a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrtx-20210930.htm Edgar Link pending
vrtx-20210930.xsd Edgar Link pending
vrtx-20210930_cal.xml Edgar Link unprocessable
vrtx-20210930_def.xml Edgar Link unprocessable
vrtx-20210930_g1.jpg Edgar Link pending
vrtx-20210930_g2.jpg Edgar Link pending
vrtx-20210930_htm.xml Edgar Link completed
vrtx-20210930_lab.xml Edgar Link unprocessable
vrtx-20210930_pre.xml Edgar Link unprocessable